Are Patents to Blame for High Drug Prices? | IPWatchdog Unleashed

Source: pharmaceuticals – IPWatchdog.com | Patents & Intellectual Property Law · Published: 2024-07-22

Pharmacy benefit managers, or simply PBMs, are often owned by either the pharmacies themselves or sometimes by insurers, which creates a lot of self-dealing to say the least. These PBMs are middlemen who receive 50% of the value of the drug, significantly raising drug prices. This has nothing to do with IP whatsoever.